Sonnet BioTherapeutics
SONN
SONN
4 hedge funds and large institutions have $1.63M invested in Sonnet BioTherapeutics in 2013 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
Holders
4
Holders Change
-1
Holders Change %
-20%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
1
Reduced
–
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BIT
1
BlackRock Institutional Trust
San Francisco,
California
|
$226K |
Top Sellers
| 1 |
TRCT
1
Tower Research Capital (TRC)
New York
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
1
Millennium Management
New York
| $1.08M | 222,222 | – | – |
|
|
BIT
2
BlackRock Institutional Trust
San Francisco,
California
| $226K | 46,294 | +1,654 | +4% |
|
|
CDH
3
Charles D. Hyman
| $217K | 44,444 | – | – |
|
4
Bank of America
Charlotte,
North Carolina
| $105K | 21,428 | – | – |
|
|
TRCT
5
Tower Research Capital (TRC)
New York
| – | – | -5,900 | Closed |
|